Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn, Germany.
Vision Res. 2021 Jan;178:124-133. doi: 10.1016/j.visres.2020.10.004. Epub 2020 Dec 30.
Assessing physiological changes that occur with healthy ageing is prerequisite for understanding pathophysiological age-related changes. Eye movements are studied as biomarkers for pathological changes because they are altered in patients with neurodegenerative disorders. However, there is a lack of data from large samples assessing age-related physiological changes and sex differences in oculomotor performance. Thus, we assessed and quantified cross-sectional relations of age and sex with oculomotor performance in the general population. We report results from the first 4,000 participants (aged 30-95 years) of the Rhineland Study, a community-based prospective cohort study in Bonn, Germany. Participants completed fixation, smooth pursuit, prosaccade and antisaccade tasks. We quantified associations of age and sex with oculomotor outcomes using multivariable linear regression models. Performance in 12 out of 18 oculomotor measures declined with increasing age. No differences between age groups were observed in five antisaccade outcomes (amplitude-adjusted and unadjusted peak velocity, amplitude gain, spatial error and percentage of corrected errors) and for blink rate during fixation. Small sex differences occurred in smooth pursuit velocity gain (men have higher gain) and blink rate during fixation (men blink less). We conclude that performance declines with age in two thirds of oculomotor outcomes but that there was no evidence of sex differences in eye movement performance except for two outcomes. Since the percentage of corrected antisaccade errors was not associated with age but is known to be affected by pathological cognitive decline, it represents a promising candidate preclinical biomarker of neurodegeneration.
评估与健康衰老相关的生理变化是理解与病理相关的衰老变化的先决条件。眼球运动被研究为病理变化的生物标志物,因为在神经退行性疾病患者中它们会发生改变。然而,缺乏大样本评估眼动表现的与年龄相关的生理变化和性别差异的数据。因此,我们评估和量化了一般人群中眼球运动表现与年龄和性别的横断面关系。我们报告了德国波恩的一项基于社区的前瞻性队列研究——莱茵兰研究中前 4000 名参与者(年龄 30-95 岁)的结果。参与者完成了注视、平滑追踪、注视转移和反向注视任务。我们使用多变量线性回归模型来量化年龄和性别与眼球运动结果之间的关联。在 18 项眼球运动测量中有 12 项的表现随着年龄的增长而下降。在五个反向注视结果(幅度调整和未调整的峰值速度、幅度增益、空间误差和校正错误的百分比)和注视期间的眨眼率方面,各年龄组之间没有差异。在平滑追踪速度增益(男性增益更高)和注视期间的眨眼率(男性眨眼次数较少)方面存在较小的性别差异。我们得出结论,在三分之二的眼球运动结果中,表现随着年龄的增长而下降,但除了两个结果外,没有证据表明眼球运动表现存在性别差异。由于校正后的反向注视错误的百分比与年龄无关,但已知会受到病理性认知能力下降的影响,因此它代表了神经退行性变的有前途的临床前生物标志物候选者。